JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 47 filers reported holding JANUX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,604 | -45.6% | 14,544 | -36.0% | 0.00% | – |
| Q2 2023 | $269,675 | +40.2% | 22,719 | +55.6% | 0.00% | – |
| Q4 2022 | $192,322 | +1.2% | 14,603 | +4.0% | 0.00% | – |
| Q3 2022 | $190,000 | -2.1% | 14,047 | -11.5% | 0.00% | – |
| Q2 2022 | $194,000 | -24.5% | 15,864 | -11.5% | 0.00% | – |
| Q1 2022 | $257,000 | -11.7% | 17,934 | +21.6% | 0.00% | – |
| Q4 2021 | $291,000 | -83.1% | 14,748 | -78.6% | 0.00% | – |
| Q2 2021 | $1,722,000 | – | 69,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |